Whole genome sequencing providing new treatment options for patients with primary immunodeficiency disorders
2 July, 2021

Professor Stuart Tangye, a speaker at the Royal College of Pathologists of Australasia’s (RCPA) annual conference, explains how next generation sequencing (NGS) for the diagnosis of primary immunodeficiencies (PID) is providing increased opportunities for precision or personalised medicine. This comes following the recent discovery of many new gene defects, with implications for many patients.

Go Back

Page last updated:

Copyright © 2021 RCPA. All rights reserved.